Norges Bank Esperion Therapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2024	BUY	$1.46 - $7.3 $1.07 Million - $5.37 Million	735,900 New	735,900 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $3.75 Million - $6.26 Million	735,900 New	735,900 $4.58 Million
Q3 2021 Nov 05, 2021	SELL	$11.34 - $21.37 $2.15 Million - $4.06 Million	-189,931 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$19.4 - $28.71 $3.68 Million - $5.45 Million	189,931 New	189,931 $4.02 Million
Q2 2021 Aug 10, 2021	SELL	$19.4 - $28.71 $4.42 Million - $6.54 Million	-227,943 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$25.12 - $36.89 $5.73 Million - $8.41 Million	227,943 New	227,943 $6.39 Million
Q1 2021 May 07, 2021	SELL	$25.12 - $36.89 $6.72 Million - $9.87 Million	-267,560 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$24.2 - $35.76 $6.47 Million - $9.57 Million	267,560 New	267,560 $6.96 Million
Q4 2020 Feb 10, 2021	SELL	$24.2 - $35.76 $6.65 Million - $9.83 Million	-274,752 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$31.18 - $52.71 $8.57 Million - $14.5 Million	274,752 New	274,752 $10.2 Million
Q3 2020 Nov 10, 2020	SELL	$31.18 - $52.71 $9.38 Million - $15.9 Million	-300,773 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$30.04 - $51.31 $9.04 Million - $15.4 Million	300,773 New	300,773 $15.4 Million
Q2 2020 Aug 07, 2020	SELL	$30.04 - $51.31 $9.42 Million - $16.1 Million	-313,569 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$27.44 - $73.84 $8.6 Million - $23.2 Million	313,569 New	313,569 $9.89 Million
Q1 2020 May 08, 2020	SELL	$27.44 - $73.84 $8.6 Million - $23.2 Million	-313,569 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$35.4 - $59.82 $11.1 Million - $18.8 Million	313,569 New	313,569 $18.7 Million
Q4 2019 Feb 12, 2020	SELL	$35.4 - $59.82 $11.1 Million - $18.8 Million	-313,569 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$34.47 - $47.53 $10.8 Million - $14.9 Million	313,569 New	313,569 $11.5 Million
Q3 2019 Nov 08, 2019	SELL	$34.47 - $47.53 $10.4 Million - $14.3 Million	-300,957 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$40.1 - $52.33 $12.1 Million - $15.7 Million	300,957 New	300,957 $14 Million
Q2 2019 Aug 09, 2019	SELL	$40.1 - $52.33 $6.69 Million - $8.73 Million	-166,861 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$40.11 - $53.57 $1.87 Million - $2.49 Million	46,511 Added 38.65%	166,861 $6.7 Million
Q4 2018 Mar 04, 2019	BUY	$36.99 - $59.11 $4.45 Million - $7.11 Million	120,350 New	120,350 $5.54 Million
Q4 2018 Feb 08, 2019	SELL	$36.99 - $59.11 $4.45 Million - $7.11 Million	-120,350 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$40.74 - $51.41 $4.9 Million - $6.19 Million	120,350 New	120,350 $5.34 Million
Q3 2018 Nov 09, 2018	SELL	$40.74 - $51.41 $4.9 Million - $6.19 Million	-120,350 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$36.2 - $76.4 $4.36 Million - $9.19 Million	120,350 New	120,350 $4.72 Million
Q2 2018 Jul 23, 2018	SELL	$36.2 - $76.4 $3.83 Million - $8.09 Million	-105,859 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$65.94 - $80.76 $6.98 Million - $8.55 Million	105,859 New	105,859 $7.66 Million

Others Institutions Holding ESPR

# of Institutions

209

Shares Held

129M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $140M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account